2015-08-14T16:50:41-05:00 2014-12-31 870381988 PINNOCK ROBBINS POSEY & RICHINS PC 215 S STATE ST STE 850 SALT LAKE CITY UT 841112380 990EZ 2014-01-01 455354811 CROWDCARE FOUNDATION CROW 8019491034 3315 MAYFLOWER DR ROOM/SUITE 1 LEHI UT 84043 JENNIFER AHLSTROM PRESIDENT 8019491034 2015-08-04 true GREGORY O HYDE P00641196 8015330409 2015-08-14 2014 2016-03-07 17:11:31Z X WWW.CROWDCARE.ORG X X 94697 X 94515 182 94697 20248 43699 63947 30750 -6020 24730 X 162 31581 5491 162 37072 6182 12342 -6020 24730 X A PATIENT-CENTERED APPROACH TO HEALTHCARE INNOVATION FOR RARE CANCERS AND ORPHAN DISEASES. PATIENT SUPPORT AND ADVOCACY (PSA): WITH A PATIENT'S PERSPECTIVE, THE CROWDCARE FOUNDATION SOLVES COMMON PROBLEMS FOR PATIENTS WITH ORPHAN DISEASES USING PRACTICAL AND SIMPLE SOLUTIONS. THE MYELOMA CROWD (WWW.MYELOMACROWD.ORG) AND ALS CROWD (ALSCROWD.ORG) WEBSITES OFFER AGGREGATED INFORMATION AND THE LATEST NEWS AND INFORMATION ABOUT THE LATEST IN RESEARCH FOR EACH DISEASE COMMUNITY. ADDITIONALLY, THE CROWDCARE FOUNDATION CREATED A MUSIC ALBUM (SONGS FOR LIFE) FOR AND BY CANCER PATIENTS, AS WELL AS USEFUL TOOLS THAT PATIENTS CAN USE WHILE IN THE CLINIC: MY DOC NOTES AND CHEMO BRAIN DOC NOTES. 19008 PATIENT EDUCATION (PED): EDUCATED PATIENTS CAN MAKE INFORMED AND CRITICAL DECISIONS. THE CROWDCARE FOUNDATION AIMS TO ARM PATIENTS WITH EASY-TO- UNDERSTAND INFORMATION ABOUT THEIR LITTLE-KNOWN DISEASE IN A VARIETY OF WAYS. THE MYELOMA CROWD AND ALS CROWD SITES HELP EDUCATE PATIENTS ABOUT THE VERY LATEST RESEARCH DIRECTLY FROM WORLD-LEADING RESEARCHERS AND CLINICIANS IN THE FIELDS OF MYELOMA AND ALS. 15955 SUPPORT FOR CLINICAL TRIALS (SCT): THE CROWDCARE FOUNDATION RECOGNIZES THAT LITTLE-KNOWN DISEASES PROVIDE A SIGNIFICANT CHALLENGE: THERE AREN'T THAT MANY PATIENTS TO PARTICIPATE IN CLINICAL RESEARCH. THE CROWDCARE FOUNDATION AIMS TO PROMOTE CLINICAL TRIAL PARTICIPATION TO HELP ACCELERATE THE PACE OF MEDICAL RESEARCH. THE MPATIENT MYELOMA RADIO SHOW (WWW.MPATIENT.ORG) AND ALS CROWD RADIO SHOW (WWW.ALSCROWD.ORG) INTERVIEW TOP SPECIALISTS FOR EACH DISEASE SO PATIENTS CAN BETTER UNDERSTAND THEIR CLINICAL TRIAL OPTIONS AND OPPORTUNITIES. THESE SHOWS HAVE BEEN HIGHLY EFFECTIVE AS A CLINICAL TRIAL RECRUITMENT TOOL TO ASSIST PATIENTS IN UNDERSTANDING THE LATEST DRUGS IN DEVELOPMENT FOR THEIR DISEASE. 17236 SUPPORT FOR RESEARCH: A CURE FOR ORPHAN DISEASES LIKE MULTIPLE MYELOMA, ALS AND OTHER LIFE-THREATENING DISEASES IS THE ULTIMATE GOAL. THE CROWDCARE FOUNDATION AIMS TO HELP DRIVE NEW RESEARCH BY CROWD-FUNDING FOR KEY RESEARCH INITIATIVES TARGETED AT RARE DISEASES. THIS INITIATIVE WILL BEGIN IN 2015. 52199 JENNIFER AHLSTROM PRESIDENT 60.00 0 GARY SAMS BOARD MEMBER 1.00 0 NEAL HARRIS BOARD MEMBER 1.00 0 SONDRA HUDGENS SECRETARY/TR 1.00 0 SETH CHRISTENSEN BOARD MEMBER 1.00 0 MICHAEL WOLFGRAMM BOARD MEMBER 1.00 0 false false false false false false false false false JENNIFER AHLSTROM 10547 SOUTH WASATCH BLVD SANDY UT 84092 8019491034 false false false false false false false false false false false NONE NONE true X 41100 56060 94515 191675 41100 56060 94515 191675 191675 191675 182 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 8 MISCELLANEOUS 182 TOTAL 182 FORM 990-EZ, PART I, LINE 16 EXPENSES ADVERTISING EXPENSE (PSA) 6,518 ADVERTISING EXPENSE (PED) 6,517 ADVERTISING EXPENSE (SCT) 6,517 BANKING FEES (PED) 229 BOOKS, SUBSCRIPTIONS (PSA) 98 BOOKS, SUBSCRIPTIONS (SCT) 99 WEB/DOMAIN SERVICES 339 POSTAGE, MAILING SERVICE 68 PRINTING AND COPYING 1,021 SUPPLIES 2,043 TELEPHONE 722 MERCHANT ACCOUNT FEES 803 PHOTOS FOR WEB SITES (PSA) 1,005 SOFTWARE (PSA) 768 TRAVEL EXPENSE (PSA) 3,438 TRAVEL EXPENSE (PED) 3,437 TRAVEL EXPENSE (SCT) 3,438 FUNDRAISING EVENTS (PSA) 1,621 FUNDRAISING EVENTS (PED) 1,621 FUNDRAISING EVENTS (SCT) 1,621 BUSINESS LICENSE 772 NON-INVESTMENT DEPRECIATION 1,004 TOTAL 43,699 FORM 990-EZ, PART II, LINE 24 LAPTOP COMPUTER 0 3,591 LESS ACCUMULATED DEPRECIATION 0 658 DELL DESKTOP COMPUTER 0 2,232 LESS ACCUMULATED DEPRECIATION 0 335 PROJECTOR 0 672 LESS ACCUMULATED DEPRECIATION 0 11 TOTAL 0 5,491 FORM 990-EZ, PART II, LINE 26 ACCOUNTS PAYABLE AND ACCRUED EXPENSES 6,182 12,342 FORM 990-EZ, PART III A PATIENT-CENTERED APPROACH TO HEALTHCARE INNOVATION FOR RARE CANCERS AND ORPHAN DISEASES. FORM 990-EZ, PART III, LINE 28 PATIENT SUPPORT AND ADVOCACY (PSA): WITH A PATIENT'S PERSPECTIVE, THE CROWDCARE FOUNDATION SOLVES COMMON PROBLEMS FOR PATIENTS WITH ORPHAN DISEASES USING PRACTICAL AND SIMPLE SOLUTIONS. THE MYELOMA CROWD (WWW.MYELOMACROWD.ORG) AND ALS CROWD (ALSCROWD.ORG) WEBSITES OFFER AGGREGATED INFORMATION AND THE LATEST NEWS AND INFORMATION ABOUT THE LATEST IN RESEARCH FOR EACH DISEASE COMMUNITY. ADDITIONALLY, THE CROWDCARE FOUNDATION CREATED A MUSIC ALBUM (SONGS FOR LIFE) FOR AND BY CANCER PATIENTS, AS WELL AS USEFUL TOOLS THAT PATIENTS CAN USE WHILE IN THE CLINIC: MY DOC NOTES AND CHEMO BRAIN DOC NOTES. FORM 990-EZ, PART III, LINE 29 PATIENT EDUCATION (PED): EDUCATED PATIENTS CAN MAKE INFORMED AND CRITICAL DECISIONS. THE CROWDCARE FOUNDATION AIMS TO ARM PATIENTS WITH EASY-TO- UNDERSTAND INFORMATION ABOUT THEIR LITTLE-KNOWN DISEASE IN A VARIETY OF WAYS. THE MYELOMA CROWD AND ALS CROWD SITES HELP EDUCATE PATIENTS ABOUT THE VERY LATEST RESEARCH DIRECTLY FROM WORLD-LEADING RESEARCHERS AND CLINICIANS IN THE FIELDS OF MYELOMA AND ALS. FORM 990-EZ, PART III, LINE 30 SUPPORT FOR CLINICAL TRIALS (SCT): THE CROWDCARE FOUNDATION RECOGNIZES THAT LITTLE-KNOWN DISEASES PROVIDE A SIGNIFICANT CHALLENGE: THERE AREN'T THAT MANY PATIENTS TO PARTICIPATE IN CLINICAL RESEARCH. THE CROWDCARE FOUNDATION AIMS TO PROMOTE CLINICAL TRIAL PARTICIPATION TO HELP ACCELERATE THE PACE OF MEDICAL RESEARCH. THE MPATIENT MYELOMA RADIO SHOW (WWW.MPATIENT.ORG) AND ALS CROWD RADIO SHOW (WWW.ALSCROWD.ORG) INTERVIEW TOP SPECIALISTS FOR EACH DISEASE SO PATIENTS CAN BETTER UNDERSTAND THEIR CLINICAL TRIAL OPTIONS AND OPPORTUNITIES. THESE SHOWS HAVE BEEN HIGHLY EFFECTIVE AS A CLINICAL TRIAL RECRUITMENT TOOL TO ASSIST PATIENTS IN UNDERSTANDING THE LATEST DRUGS IN DEVELOPMENT FOR THEIR DISEASE. FORM 990-EZ, PART III, LINE 31 SUPPORT FOR RESEARCH: A CURE FOR ORPHAN DISEASES LIKE MULTIPLE MYELOMA, ALS AND OTHER LIFE-THREATENING DISEASES IS THE ULTIMATE GOAL. THE CROWDCARE FOUNDATION AIMS TO HELP DRIVE NEW RESEARCH BY CROWD-FUNDING FOR KEY RESEARCH INITIATIVES TARGETED AT RARE DISEASES. THIS INITIATIVE WILL BEGIN IN 2015.